UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

PloS one, 2024-04, Vol.19 (4), p.e0287444-e0287444

2024

Volltextzugriff (PDF)

Pruritus in cutaneous T-cell lymphoma: A review

Journal of the American Academy of Dermatology, 2012-10, Vol.67 (4), p.760-768

2012

Volltextzugriff (PDF)

Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study

JEADV clinical practice, 2024-09, Vol.3 (4), p.1109-1118

2024

Volltextzugriff (PDF)

Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis

JAAD Case Reports, 2020-09, Vol.6 (9), p.878-881

2020

Volltextzugriff (PDF)

A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study

Frontiers in medicine, 2021-07, Vol.8, p.679294-679294

2021

Volltextzugriff (PDF)

A role for NF-κB activity in skin hyperplasia and the development of keratoacanthomata in mice

PloS one, 2013-08, Vol.8 (8), p.e71887

2013

Volltextzugriff (PDF)

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline

Oncotarget, 2015-06, Vol.6 (17), p.14796-14813

2015

Volltextzugriff (PDF)

PB2358: PHASE 1‐2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL

HemaSphere, 2023-08, Vol.7 (S3), p.e07947e7-n/a

2023

Volltextzugriff (PDF)

HyBryte™ use in early-stage cutaneous T-cell lymphoma

Frontiers in drug discovery, 2023-11, Vol.3

2023

Volltextzugriff (PDF)

Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma

Dermatologic clinics, 2015-10, Vol.33 (4), p.787-805

2015

Volltextzugriff (PDF)

The good, the bad, and the ugly of free drug samples

JAMA dermatology (Chicago, Ill.), 2014-11, Vol.150 (11), p.1237

Poligone, Brian

2014

Volltextzugriff (PDF)

Innovative Therapy of Cutaneous T-Cell Lymphoma: Beyond Psoralen and Ultraviolet Light and Nitrogen Mustard

Dermatologic clinics, 2010-07, Vol.28 (3), p.501-510

2010

Volltextzugriff (PDF)

Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

PloS one, 2024-01, Vol.19 (4), p.e0287444

2024

Volltextzugriff (PDF)

Education on Blastic Plasmacytoid Dendritic Cell Neoplasm Significantly Impacts the Interdisciplinary Physician Team

Blood, 2021-11, Vol.138 (Supplement 1), p.3021-3021

2021

Volltextzugriff (PDF)

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Core evidence, 2011-01, Vol.6, p.1-12

2011

Volltextzugriff (PDF)

Bazex syndrome (acrokeratosis paraneoplastica)

The Lancet (British edition), 2007-02, Vol.369 (9560), p.530-530

2007

Volltextzugriff (PDF)

ASTX660-01 Phase 2: A Case Study of Tolinapant-Induced Pseudoprogression in CTCL

Blood, 2023-11, Vol.142 (Supplement 1), p.6205-6205

2023

Volltextzugriff (PDF)

A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.12033-12034

2022

Volltextzugriff (PDF)

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.37-37

2020

Volltextzugriff (PDF)

Relief of intractable pruritus with romidepsin in patients with cutaneous T‐cell lymphoma: A series of four cases

Dermatologic therapy, 2019-03, Vol.32 (2), p.e12804-n/a

2019

Volltextzugriff (PDF)

021 - Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)

European journal of cancer (1990), 2019, Vol.119, p.S8-S8

2019

Volltextzugriff (PDF)

Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)

European journal of cancer (1990), 2019, Vol.119, p.S8

2019

Volltextzugriff (PDF)

Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells

Oncotarget, 2016-11, Vol.7 (46), p.75954-75967

2016

Volltextzugriff (PDF)

Positive and Negative Regulation of NF- Kappa B by COX-2: ROLES OF DIFFERENT PROSTAGLANDINS

The Journal of biological chemistry, 2001-10, Vol.276 (42), p.38658-38664

2001

Volltextzugriff (PDF)

Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure

American journal of clinical dermatology, 2018-02, Vol.19 (1), p.119-126

2018

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Dermatology
(20)
Humans
(19)
Male
(13)
Female
(11)
Mycosis Fungoides
(11)
Animals
(10)
Mice
(9)
Cutaneous T-Cell Lymphoma
(7)
Immunology
(7)
Skin Neoplasms - Pathology
(7)
Lymphoma, T-Cell, Cutaneous - Pathology
(6)
Biological And Medical Sciences
(5)
Lymphoma
(5)
Lymphoma, T-Cell, Cutaneous - Drug Therapy
(5)
Medical Sciences
(5)
Mice, Inbred Nod
(5)
Middle Aged
(5)
Nf-Kappa B - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

Pruritus in cutaneous T-cell lymphoma: A review

Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study

Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis

A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study

A role for NF-κB activity in skin hyperplasia and the development of keratoacanthomata in mice

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline

PB2358: PHASE 1‐2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL

HyBryte™ use in early-stage cutaneous T-cell lymphoma

Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma

The good, the bad, and the ugly of free drug samples

Innovative Therapy of Cutaneous T-Cell Lymphoma: Beyond Psoralen and Ultraviolet Light and Nitrogen Mustard

Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

Education on Blastic Plasmacytoid Dendritic Cell Neoplasm Significantly Impacts the Interdisciplinary Physician Team

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Bazex syndrome (acrokeratosis paraneoplastica)

ASTX660-01 Phase 2: A Case Study of Tolinapant-Induced Pseudoprogression in CTCL

A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Relief of intractable pruritus with romidepsin in patients with cutaneous T‐cell lymphoma: A series of four cases

021 - Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)

Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)

Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells

Positive and Negative Regulation of NF- Kappa B by COX-2: ROLES OF DIFFERENT PROSTAGLANDINS

Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure

Suchergebnisse filtern